IL1B and cancer: Persistent chronic inflammation in cancers, in response to the aforementioned factors, results in the activation of the transcription factor NF-kB, thereby stimulating the production of an inactive form of IL-1β, or pro-IL-1β, and the NLR family pyrin domain containing 3 protein (NLRP3) inflammasome [28,29,30].